[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"adrenocortical-tumor\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:adrenocortical-tumor":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,37,80],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":16,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":29,"completionDateStruct":31,"leadSponsor":33,"locationsCount":36},"100110300","international-pediatric-adrenocortical-tumor-registry-100110300",false,"NCT00700414","International Pediatric Adrenocortical Tumor Registry","STRATIFICATION ASSIGNMENT:\n\n* Stratum A: participant suspected or confirmed diagnosis of adrenocortical tumor (ACT)\n* Stratum R: relative of participant with ACT and TP53 mutation who has diagnosis of malignancy\n* Stratum P: biological parent of participant with ACT\n\nInclusion Criteria - Stratum A (participant with ACT):\n\n* Age ≤ 21 years old at diagnosis\n* Suspected or confirmed diagnosis of adrenocortical tumor (adenoma, carcinoma or undefined histology).\n* Signed informed consent\n\nInclusion Criteria - Stratum R (relative):\n\n* Any age\n* Diagnosis of malignant tumor\n* Signed informed consent\n\nInclusion Criteria - Stratum P (parent):\n\n* Biological parent of Stratum A participant","ALL","21 Years",{"count":18,"type":19},9999,"ESTIMATED","OBSERVATIONAL","This study aims to collect demographic and medical information including detailed family history of cancer of children and adolescents with adrenocortical tumors in order to learn more about the clinical and epidemiological aspects, treatment modalities, and outcome of patients with this rare disease, worldwide.\n\nIn addition, investigators at St. Jude Children's Research Hospital (SJCRH) plan to perform molecular studies of tumor cells aimed to clarify the role of the TP53 gene and other genetic pathways in these tumors. They aim to obtain relevant biological material from participants with adrenocortical tumor (ACT), their biological parents, and relatives for determination of the TP53 germline status, molecular studies of the TP53 gene, and other molecular pathways.",[23],"Adrenocortical Tumor","RECRUITING","2026-05-20",{"date":27,"type":28},"2026-05-22","ACTUAL",{"date":30,"type":28},"2001-10-01",{"date":32,"type":19},"2040-12",{"name":34,"class":35},"St. Jude Children's Research Hospital","OTHER",5,{"id":38,"slug":39,"hasResults":11,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":43,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":15,"minAge":45,"maxAge":46,"enrollmentInfo":47,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":49,"conditions":50,"keywords":64,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":79},"100598488","an-international-study-on-pediatric-patients-with-rare-tumors-100598488","NCT07072143","An International Study on Pediatric Patients With Rare Tumors.","The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.","PARTNER","Inclusion Criteria:\n\n* Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and\u002For treated in a participating country\u002Fcenter.\n* Written informed consent from the patient and\u002For the parent\u002Flegal guardian\n\nExclusion Criteria:\n\n* Absence of Written informed consent from the patient and\u002For the parent\u002Flegal guardian","0 Years","18 Years",{"count":48,"type":19},6250,"The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.",[51,52,53,23,54,55,56,57,58,59,60,61,62,63],"Paraganglioma\u002F Phaeochromocytoma","Melanoma and Other Malignant Neoplasms of Skin","Gastrointestinal Stromal Tumor (GIST)","Pancreatic Tumors","Esthesioneuroblastoma, Olfactory","Mesothelioma","Nasopharyngeal Carcinoma (NPC)","NUT Carcinoma","Pleuropulmonary Blastoma","Salivary Gland Tumors","Thymic Tumors","Thyroid Carcinoma","Appendiceal Cancers",[65,66,67,68,69],"children","rare tumors","very rare tumors","adolescents","PARTNER Study","2025-07-16",{"date":72,"type":28},"2025-07-18",{"date":74,"type":28},"2025-01-25",{"date":76,"type":19},"2049-06-06",{"name":78,"class":35},"Azienda Ospedaliera di Padova",1,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":4,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":15,"minAge":46,"maxAge":4,"enrollmentInfo":87,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":89,"conditions":90,"keywords":103,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":79},"100519938","surgical-treatment-of-adrenal-diseases--laparoscopic-vs-robotic-assisted-adrenalectomy-100519938","NCT06050057","Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy","Possibilities of Surgical Treatment of Adrenal Diseases: Comparison of Laparoscopic and Robotic-assisted Adrenalectomy-a Prospective Study","Inclusion Criteria:\n\n* Indicated adrenalectomy based on endocrinological and imaging examination.\n* Written consent to participate in the study.\n\nExclusion Criteria:\n\n* Simultaneous bilateral adrenalectomy.\n* Adrenal expansion \\> 12 cm.\n* Suspected malignant adrenal tumor with infiltrative growth or tumor venous thrombus according to imaging examination.",{"count":88,"type":19},100,"The goal of this multicenter, observational, analytic, randomized clinical trial is to analyze the laparoscopic and robot-assisted method in the surgical treatment of patients with adrenal diseases. The main question it aims to answer are:\n\n1. to find the superiority of one the the surgical method mentioned above\n2. to compare the quality of life in patients with adrenal mass before surgery and after laparoscopic or robotic-assisted adrenalectomy.",[91,92,93,94,95,96,97,98,99,100,101,102,23],"Adrenal Tumor","Adrenal Disease","Adrenal Mass","Adrenalectomy; Status","Adrenal Hyperplasia","Adrenal Gland Metastasis","Adrenal Cortex Diseases","Pheochromocytoma","Cushing Syndrome","Conn Adenoma","Adrenocortical Carcinoma","Adrenocortical Adenoma",[91,98,100,99,104,105,106],"Adrenalectomy","Laparoscopic surgery","da Vinci surgical system","2023-09-17",{"date":109,"type":28},"2023-09-22",{"date":111,"type":28},"2023-09-03",{"date":113,"type":19},"2026-06-30",{"name":115,"class":35},"University Hospital Olomouc"]